MYD Stock Forecast - Myriad Genetics Inc

M	Myriad Genetics Inc XHAM:MYD	US
	Dios Fastigheter AB STO:DIOS	SE
	Brightstar Resources Ltd OTC:BTRAF	AU
E	EMCOR Group Inc F:EM4	US
	Zehnder Group AG LSE:0R6S	CH
P	Pharmaniaga Bhd KLSE:PHARMA	MY
	Dovalue SpA MIL:DOV	IT
H	Highland Copper Company Inc OTC:HDRSF	CA
	Garrett Motion Inc NASDAQ:GTX	CH
	Leonteq AG SIX:LEON	CH
	Edgio Inc NASDAQ:EGIO	US
	Happy Valley Nutrition Ltd ASX:HVM	NZ
	Hikari Tsushin Inc TSE:9435	JP
	Noxopharm Ltd ASX:NOX	AU
	Ginting Jaya Energi Tbk PT IDX:WOWS	ID
J	JK Paper Ltd BSE:532162	IN
L	L'Occitane International SA SWB:COC	LU
	Screen Holdings Co Ltd TSE:7735	JP
H	Huazhu Group Ltd NASDAQ:HTHT	CN
M	Magellan Aerospace Corp OTC:MALJF	CA
	Ki-Star Real Estate Co Ltd TSE:3465	JP
A	Asuransi Maximus Graha Persada Tbk PT IDX:ASMI	ID
	Ascencio SCA XBRU:ASCE	BE
	PennyMac Financial Services Inc NYSE:PFSI	US

Wall St Price Targets

Wall Street analysts forecast MYD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MYD is 5.619 EUR with a low forecast of 3.577 EUR and a high forecast of 9.296 EUR.

12% Downside

39% Upside

130% Upside

CoStar Group Inc

52% Upside

Medpace Holdings Inc

-1% Downside

Quinstreet Inc

66% Upside

News Corp

30% Upside

CoStar Group Inc

52% Upside

Medpace Holdings Inc

-1% Downside

Quinstreet Inc

66% Upside

News Corp

30% Upside

Protagonist Therapeutics Inc

23% Upside

American Resources Corp

190% Upside

Revenue
Forecast

5% / Year

Past Growth

5% / Year

Estimated Growth

Estimates Accuracy

-2%

Average Miss

5% / Year

Past Growth

5% / Year

Estimated Growth

Estimates Accuracy

-2%

Average Miss

Over the last 4 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 5 years is 5%.

What are analyst estimates?

Gross Profit
Forecast

4% / Year

Past Growth

N/A

Estimated Growth

N/A

Estimates Accuracy

N/A

Average Beat/Miss

4% / Year

Past Growth

N/A

Estimated Growth

N/A

Estimates Accuracy

N/A

Average Beat/Miss

Operating Income
Forecast

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

N/A

Average Beat/Miss

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

N/A

Average Beat/Miss

What are analyst estimates?

Pre-Tax Income
Forecast

N/A

Past Growth

N/A

Estimated Growth

N/A

Estimates Accuracy

N/A

Average Beat/Miss

N/A

Past Growth

N/A

Estimated Growth

N/A

Estimates Accuracy

N/A

Average Beat/Miss

Net Income
Forecast

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

N/A

Average Beat/Miss

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

N/A

Average Beat/Miss

What are analyst estimates?

Myriad Genetics Inc
XHAM:MYD

Wall St Price Targets

MYD Price Targets Summary
Myriad Genetics Inc

Revenue
Forecast

Gross Profit
Forecast

Operating Income
Forecast

Pre-Tax Income
Forecast

Net Income
Forecast

See Also

What is MYD's stock price target?

Price Target
5.619 EUR

What is the Revenue forecast for Myriad Genetics Inc?

Projected CAGR
5%

Company

Help

Tools

Stocks

Myriad Genetics Inc XHAM:MYD

Wall St Price Targets

MYD Price Targets Summary Myriad Genetics Inc

Revenue Forecast

Gross Profit Forecast

Operating Income Forecast

Pre-Tax Income Forecast

Net Income Forecast

See Also

What is MYD's stock price target? Price Target 5.619 EUR

What is the Revenue forecast for Myriad Genetics Inc? Projected CAGR 5%

Company

Help

Tools

Stocks

Myriad Genetics Inc
XHAM:MYD

MYD Price Targets Summary
Myriad Genetics Inc

Revenue
Forecast

Gross Profit
Forecast

Operating Income
Forecast

Pre-Tax Income
Forecast

Net Income
Forecast

What is MYD's stock price target?

Price Target
5.619 EUR

What is the Revenue forecast for Myriad Genetics Inc?

Projected CAGR
5%